inflammation/edema

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 141 rezilta yo

Electromagnetic method of treatment of lesions associated with inadequate blood perfusion, partial denervation, tissue loss, pain, edema, inflammation and infection

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to a method for treatment of skin lesions and internal wounds such as viable but underperfused myocardium. More specifically, this invention is related to a method for treatment of a subject afflicted with

3,4-Dihydrospiro-2H-1,3-benzoxazines and their use in treating edema, abnormal electrolyte retention, and inflammation

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This invention is concerned with novel 3,4-dihydrospiro-2H-1,3-benzoxazines having therapeutic utility, processes for their preparation, methods of treating inflammation, edema and autoimmune diseases, and novel pharmaceutical formulations comprising at least one of the novel compounds as active

Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a national phase application of PCT Application No. PCT/KR2015/002640, filed on Mar. 18, 2015, which claims the benefit and priority to Korean Patent Application No. 10-2014-0031624, filed Mar. 18, 2014. The entire disclosures of the

Composition for treating inflammatory brain diseases which includes stem cell as active ingredient

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNICAL FIELD The present invention relates to a composition for treating inflammatory brain diseases, comprising stem cells as an active ingredient. BACKGROUND ART Stem cells refer to cells having the ability to self-replicate and the ability to differentiate into at least two cells and can be

Prophylactic and therapeutic methods for treating edema with antamanides

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

GOVERNMENTAL SUPPORT Research support for the present invention was provided by U.S. Public Health Service NHLB Grants Numbers HL16714 and HL33104. FIELD OF THE INVENTION The present invention is concerned with inflammatory and non-inflammatory associated edemas and is particularly directed to

Prophylactic and therapeutic methods for treating interleukin-mediated edemas

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The present invention is concerned with inflammatory and non-inflammatory (hydraulic) associated edemas and is particularly directed to prophylactic and therapeutic methods for treating localized and systemic edemas caused or mediated by interleukins. BACKGROUND OF THE

Method of inhibiting inflammatory response

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION This invention generally relates to a method of inhibiting an inflammatory response of skin or mucosal membranes to injury, and more particularly to the use certain neuropeptides, particularly of Corticotropin Releasing Factor and its analogs, in attenuating inflammation of

Pharmaceutical composition for preventing or treating inflammatory diseases comprising trachelospermi caulis extract and paeonia suffruticosa andrews extract, and method for preparing the same

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CROSS-REFERENCES TO RELATED APPLICATIONS This application is a U.S. national phase application of International PCT Patent Application No. PCT/KR2011/006094, which was filed on Aug. 18, 2011, which claims priority to Korean Patent Application Nos. 10-2010-0123086, filed Dec. 3, 2010;

2,3-di-substituted-5,6-dihydroimidazo [2,1-b] thiazole, its salts, production thereof and anti-inflammatory agent containing the same

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This invention relates to novel imidazothiazole derivatives, their salts, a method for the production thereof, and anti-inflammatory compositions containing the same. More particularly, this invention relates to 2,3-di-substituted-5,6-dihydroimidazo [2,1-b] thiazole, its salts, a method for the

2,-3-Di-substituted-5,6-dihydroimidazo [2,1-b] thiazole, its salts, production thereof and anti-inflammatory agent containing the same

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Triazine derivatives to treat pain, fever, inflammation, allergies and thrombosis

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

N-nicotinoylhalogenobenzoguanamines are known in the art to exhibit strong anti-inflammatory action (see Japanese patent application No. 56-87124). It has now been discovered that triazine derivatives of the formula (I): ##STR2## and pharmaceutically acceptable salts thereof wherein R.sup.1 and

Method for treating inflammation, arthritis or disc diseases using a mixed extract of cibotii rhizoma, ledebouriellae radix, achyranthis radix, paeonia lactiflora pall and glycyrrhizae radix

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for treating inflammatory or degenerative diseases by administering to an individual a pharmaceutically effective amount of a mixed extract of Cibotii Rhizoma, Ledebouriellae Radix, Achyranthis Radix,

Plasminogen activator as an anti-inflammatory agent

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the use of plasminogen activator as an anti-inflammatory agent. 2. Description of the Related Art Plasminogen activators play an important physiological role in the regulation of thrombolysis. This action is

Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The invention relates to the field of pathological angiogenesis and arteriogenesis. In particular, the invention describes a stress-induced phenotype in a transgenic mouse (PIGF-) that does not produce Placental Growth Factor (PIGF) and that demonstrates an impaired vascular

LIF for use in modulating inflammation and pain

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION This invention is related to the use of leukemia inhibitory factor (LIF) and other agonists of the LIF receptor, in the regulation of inflammation and pain. BACKGROUND Leukemia inhibitory factor (LIF) belongs to the neuropoietic cytokine family, which also includes ciliary

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye